メドレックス
4586
東証グロース
医薬品
メドレックスの決算推移
損益計算書
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|---|
売上高 | 26 | 37 | 22 | 198 | 8 | 169 | 115 | 8 | 59 | 29 |
売上原価 | 9 | 12 | 7 | 7 | 2 | 5 | 3 | 2 | 2 | 2 |
売上総利益 | 16 | 25 | 14 | 191 | 5 | 164 | 111 | 6 | 56 | 27 |
販管費 | 1,020 | 1,025 | 1,357 | 1,174 | 1,279 | 1,792 | 1,241 | 1,067 | 1,155 | 960 |
営業利益 | -1,004 | -1,000 | -1,343 | -984 | -1,274 | -1,628 | -1,131 | -1,062 | -1,099 | -934 |
営業外収益 | 21 | 22 | 55 | 5 | 5 | 12 | 1 | 1 | 1 | 14 |
営業外費用 | 30 | 13 | 13 | 10 | 17 | 18 | 23 | 14 | 14 | 11 |
経常利益 | -1,013 | -991 | -1,302 | -989 | -1,286 | -1,634 | -1,153 | -1,075 | -1,113 | -931 |
特別利益 | N/A | 116 | 46 | 143 | 19 | 21 | 45 | 15 | 2 | 0 |
特別損失 | N/A | N/A | N/A | 34 | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | -1,017 | -879 | -1,260 | -885 | -1,268 | -1,617 | -1,115 | -1,060 | -1,112 | -933 |
貸借対照表
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|---|
資産 | 3,685 | 2,977 | 3,079 | 2,133 | 2,311 | 2,047 | 2,297 | 2,108 | 1,398 | 2,052 |
流動資産 | 2,853 | 2,204 | 2,736 | 1,836 | 1,937 | 1,501 | 1,886 | 1,754 | 1,087 | 1,785 |
現金及び預金 | 2,780 | 2,062 | 2,639 | 1,737 | 1,796 | 1,410 | 1,812 | 1,703 | 994 | 1,720 |
売上債権 | 0 | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
棚卸資産 | 19 | 26 | 23 | 34 | 42 | 18 | 19 | 11 | 8 | 10 |
固定資産 | 831 | 773 | 342 | 296 | 373 | 546 | 410 | 353 | 311 | 267 |
負債 | 170 | 205 | 572 | 99 | 180 | 126 | 149 | 153 | 185 | 127 |
流動負債 | 78 | 109 | 103 | 88 | 170 | 116 | 122 | 125 | 158 | 99 |
仕入債務 | 0 | 0 | 0 | N/A | 0 | N/A | N/A | N/A | N/A | N/A |
固定負債 | 91 | 95 | 469 | 10 | 10 | 10 | 27 | 27 | 27 | 27 |
純資産 | 3,514 | 2,772 | 2,506 | 2,034 | 2,130 | 1,920 | 2,147 | 1,955 | 1,212 | 1,924 |
利益剰余金 | -5,200 | -6,078 | -7,337 | -8,222 | -9,489 | -11,106 | -12,220 | -13,280 | -2,151 | -916 |
自己株式 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 0 |